Company / EPS (Basic)
Zimmer Biomet EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$4.91
FY2025
5-year range
-$0.67 / $5.52
FY2021-FY2025
Trend
+346.4%
vs FY2024
Sector context
#36 of 160
Health Care
What the data says
EPS (Basic) changed +346% YoY in FY2025, a notable deviation from the 9-year average annual change of +151%.
Based on SEC 10-K filings.
4.91 in FY2025. Top quartile in the Health Care sector.
Improved from $1.93 to $4.91 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 160This company $4.91 Sector average $1.57
▼
+211.9% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 346.4% year-over-year.
- Ranks #36 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2019.
- Lowest eps (basic) in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.91 | +346.4% |
| FY2024 | $1.10 | -43.0% |
| FY2023 | $1.93 | +388.1% |
| FY2022 | -$0.67 | -112.1% |
| FY2021 | $5.52 | +396.8% |
| FY2020 | -$1.86 | -120.7% |
| FY2019 | $8.98 | +486.9% |
| FY2018 | $1.53 | +96.2% |
| FY2017 | $0.78 | -81.7% |
| FY2016 | $4.26 | -7.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026